Action Roche (QX) - RHHBY

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

39,77

Prix Achat

39,62

Prix Vente

40,11

Volume échangé

1 443 967

39,67 Fourchette du Jour 40,07

29,20 Plage de 52 semaines 42,43

Cap du marché

254,099B

Clôture Veille

39,61

Ouverture

40,03

Dernière Transaction

39.77

Dernière heure de transaction

Volume financier

US$ 57 535 840

VWAP

39,8457

Volume moyen (3 m)

1 448 195

Actions en circulation

6 389 213 336

Rendement du Dividende

3.39%

Ratio Cours sur Bénéfices

0,00

Bénéfice par action (BPA)

Chiffre d'affairess

58,72B

Bénéfice net

11,5B

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.roche.com

Siège social

Basel, Che

Fondé

Roche Holdings Ltd AG (QX) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker RHHBY. Le dernier cours de clôture d'Roche (QX) était de US$39,61. Au cours de la dernière année, les actions de Roche (QX) ont été négociées dans une fourchette de prix de US$ 29,20 à US$ 42,43.

Roche (QX) compte actuellement 6 389 213 336 actions en circulation. La capitalisation boursière d'Roche (QX) est de US$253,08 milliard.

GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons

January 10, 2024 -- InvestorsHub NewsWire -- via NetworkNewsWire Editorial Coverage: On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved...

Form 3 - Initial statement of beneficial ownership of securities

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

September 20, 2023 -- InvestorsHub NewsWire -- via NetworkNewsWire Editorial Coverage: More than 30 million people in the United States suffer with a rare disease; most of them are...

Roche to provide HIV diagnostic solutions to Global Fund

Roche to provide HIV diagnostic solutions to Global Fund PR Newswire PLEASANTON, California, June 18, 2015 - Framework agreement with Global Fund strengthens access to HIV diagnostics ...

Clinical value of Roche's CINtec® PLUS Cytology test confirmed for women with abnormal cervical cytology screening results

Clinical value of Roche's CINtec® PLUS Cytology test confirmed for women with abnormal cervical cytology screening results PR Newswire TUCSON, Ariz., June 16, 2015 TUCSON, Ariz., June 16, 2015...

Ventana receives FDA approval for the first fully automated IHC companion diagnostic to identify lung cancer patients eligibl...

Ventana receives FDA approval for the first fully automated IHC companion diagnostic to identify lung cancer patients eligible for XALKORI® (crizotinib) PR Newswire TUCSON, Arizona, June 15, 2015...

Ariosa receives CE mark for its FORTE Software to support Harmony™ Prenatal Test

Ariosa receives CE mark for its FORTE Software to support Harmony™ Prenatal Test PR Newswire SAN JOSE, Calif., June 11, 2015 SAN JOSE, Calif., June 11, 2015 /PRNewswire/ -- Roche (SIX: RO, ROG;...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.56	1.42820709003	39.21	40.65	38.7825	1436092	39.73935521	DR
4	3.02	8.21768707483	36.75	40.65	35.85	1852283	37.92548703	DR
12	3.87	10.7799442897	35.9	40.65	34.103	1448195	36.62134107	DR
26	0.11	0.277357539082	39.66	42.43	34.103	1391840	38.22475829	DR
52	6.93	21.1023142509	32.84	42.43	29.2	1985101	34.69055099	DR
156	-6.67	-14.3626184324	46.44	53.86	27.95	1886416	37.75320889	DR
260	-3.59	-8.2795202952	43.36	53.86	27.95	1754842	39.87990447	DR

RHHBY - Frequently Asked Questions (FAQ)

What is the current Roche (QX) share price?

The current share price of Roche (QX) is US$ 39,77

How many Roche (QX) shares are in issue?

Roche (QX) has 6 389 213 336 shares in issue

What is the market cap of Roche (QX)?

The market capitalisation of Roche (QX) is USD 253,08B

What is the 1 year trading range for Roche (QX) share price?

Roche (QX) has traded in the range of US$ 29,20 to US$ 42,43 during the past year

What is the reporting currency for Roche (QX)?

Roche (QX) reports financial results in CHF

What is the latest annual turnover for Roche (QX)?

The latest annual turnover of Roche (QX) is CHF 58,72B

What is the latest annual profit for Roche (QX)?

The latest annual profit of Roche (QX) is CHF 11,5B

What is the registered address of Roche (QX)?

The registered address for Roche (QX) is GRENZACHERSTRASSE 124, BASEL, 4070

What is the Roche (QX) website address?

The website address for Roche (QX) is www.roche.com

Which industry sector does Roche (QX) operate in?

Roche (QX) operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
SHWZMedicine Man Technologies Inc (CE)	US$ 0,0011 (109 900,00%)	530
ZHCLFZenith Capital Corporation (CE)	US$ 0,10 (99 900,00%)	6k
GNCAQGenocea Biosciences Inc (CE)	US$ 0,0005 (49 900,00%)	2k
CCTLCoin Citadel (PK)	US$ 0,0002 (19 900,00%)	509,6k
TPTWTPT Global Tech Inc (CE)	US$ 0,0002 (19 900,00%)	25,08M
BRGOBergio International Inc (PK)	US$ 0,000001 (-99,00%)	502k
POLCQPolished Inc (CE)	US$ 0,000001 (-99,00%)	130
PUGEPuget Technologies Inc (CE)	US$ 0,000001 (-99,00%)	169k
COSGCosmos Group Holdings Inc (PK)	US$ 0,000001 (-99,00%)	10M
RNWFRenewal Fuels Inc (CE)	US$ 0,000001 (-99,00%)	133
IMTLImage Protect Inc (PK)	US$ 0,0001 (-33,33%)	289,87M
ABQQAB International Group Corporation (PK)	US$ 0,0003 (-25,00%)	286,78M
PDGOParadigm Oil and Gas Inc (PK)	US$ 0,0001 (0,00%)	225,08M
BOMObowmo Inc (PK)	US$ 0,0005 (66,67%)	211,25M
RONNRonn Motor Group Inc (PK)	US$ 0,0003 (0,00%)	187,29M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Roche Holdings Ltd AG (QX) (RHHBY)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Roche Holdings Ltd AG (QX)

RHHBY Dernières nouvelles

GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons

Form 3 - Initial statement of beneficial ownership of securities

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

Roche to provide HIV diagnostic solutions to Global Fund

Clinical value of Roche's CINtec® PLUS Cytology test confirmed for women with abnormal cervical cytology screening results

Ventana receives FDA approval for the first fully automated IHC companion diagnostic to identify lung cancer patients eligibl...

Ariosa receives CE mark for its FORTE Software to support Harmony™ Prenatal Test

RHHBY - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Roche Holdings Ltd AG (QX) (RHHBY) Cours

Roche Holdings Ltd AG (QX) (RHHBY)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Roche Holdings Ltd AG (QX)

RHHBY Dernières nouvelles

GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons

Form 3 - Initial statement of beneficial ownership of securities

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

Roche to provide HIV diagnostic solutions to Global Fund

Clinical value of Roche's CINtec® PLUS Cytology test confirmed for women with abnormal cervical cytology screening results

Ventana receives FDA approval for the first fully automated IHC companion diagnostic to identify lung cancer patients eligibl...

Ariosa receives CE mark for its FORTE Software to support Harmony™ Prenatal Test

RHHBY - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités